Profit Or Loss [Abstract]

Oxford Biomedica PLC - Filing #5873329

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	12 8,7 97 GBP	—	—	—	—	—	—	—	—	89 ,53 9 GBP	—	—	—	—	—	—
Other income	—	—	5, 254 GBP	—	—	—	—	—	—	—	—	2, 803 GBP	—	—	—	—	—	—
Profit (loss) from operating activities	—	—	3 9,3 75 GBP	—	—	—	—	—	—	—	—	18 4,1 74 GBP	—	—	—	—	—	—
Finance income	—	—	3, 236 GBP	—	—	—	—	—	—	—	—	4, 910 GBP	—	—	—	—	—	—
Finance costs	—	—	1 1,1 26 GBP	—	—	—	—	—	—	—	—	9, 263 GBP	—	—	—	—	—	—
Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9	—	—	- GBP	—	—	—	—	—	—	—	—	9 9,2 84 GBP	—	—	—	—	—	—
Profit (loss) before tax	—	—	4 7,2 65 GBP	—	—	—	—	—	—	—	—	18 8,5 27 GBP	—	—	—	—	—	—
Tax expense (income)	—	—	1 ,34 4 GBP	—	—	—	—	—	—	—	—	4,3 65 GBP	—	—	—	—	—	—
Profit (loss)	5,4 19 GBP	- GBP	4 8,6 09 GBP	- GBP	- GBP	- GBP	- GBP	43 ,1 90 GBP	4 3,1 90 GBP	- GBP	- GBP	18 4,1 62 GBP	2 6,6 72 GBP	- GBP	- GBP	- GBP	157 ,4 90 GBP	15 7,4 90 GBP
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	—	4 3,1 90 GBP	—	—	—	—	—	—	—	—	15 7,4 90 GBP	—	—	—	—	—	—
Profit (loss), attributable to non-controlling interests	—	—	5 ,41 9 GBP	—	—	—	—	—	—	—	—	26 ,6 72 GBP	—	—	—	—	—	—
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Diluted earnings per share [abstract]
Diluted earnings (loss) per share	—	—	4 1.7 5	—	—	—	—	—	—	—	—	16 3. 11	—	—	—	—	—	—